Rani Therapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Rani Therapeutics (RANI) IPO Opens Modestly Higher After Weak Pricing
July 30, 2021 12:08 PM EDTToday's IPO for Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) opened for trading at $11.26 after pricing 6,666,667 shares of Class A common stock at a price to the public of $11.00 per share, below the expected $14-$16 range.
BofA Securities, Stifel, Cantor Fitzgerald and Canaccord... More
